NCT02761616View on ClinicalTrials.gov

A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Breast Cancer
Interventions
OTHER

eBC treated participants

No intervention administered in this retrospective observational study.

Trial Locations (4)

C1431FWO

Cemic; Oncologia Clinica, Buenos Aires

Unknown

Hospital de Morón, Morón

CENICLAR, Rosario

T4000IAK

Centro Medico San Roque, San Miguel de Tucumán

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02761616 - A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer | Biotech Hunter | Biotech Hunter